Assyro AI

FDA Orange Book · active-ingredient family

Cefoperazone sodium

Cefoperazone sodium is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

2

Brand (NDA)

1

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
CEFOBID IN PLASTIC CONTAINER×2PFIZERNDA 050613Jul 31, 1987
CEFOBID×3PFIZERNDA 050551Nov 18, 1982

Generic (ANDA) products (1)

ProductApplicantApplicationTEApproved
CEFOBID×2PFIZERANDA 063333Mar 31, 1995

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Cefoperazone sodium — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.